1. Home
  2. ITOS vs BLDP Comparison

ITOS vs BLDP Comparison

Compare ITOS & BLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • BLDP
  • Stock Information
  • Founded
  • ITOS 2011
  • BLDP 1979
  • Country
  • ITOS United States
  • BLDP Canada
  • Employees
  • ITOS N/A
  • BLDP N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • BLDP Industrial Machinery/Components
  • Sector
  • ITOS Health Care
  • BLDP Energy
  • Exchange
  • ITOS Nasdaq
  • BLDP Nasdaq
  • Market Cap
  • ITOS 446.6M
  • BLDP 479.7M
  • IPO Year
  • ITOS 2020
  • BLDP 1995
  • Fundamental
  • Price
  • ITOS $10.11
  • BLDP $2.00
  • Analyst Decision
  • ITOS Hold
  • BLDP Sell
  • Analyst Count
  • ITOS 6
  • BLDP 9
  • Target Price
  • ITOS $10.40
  • BLDP $1.50
  • AVG Volume (30 Days)
  • ITOS 1.6M
  • BLDP 5.7M
  • Earning Date
  • ITOS 08-06-2025
  • BLDP 08-11-2025
  • Dividend Yield
  • ITOS N/A
  • BLDP N/A
  • EPS Growth
  • ITOS N/A
  • BLDP N/A
  • EPS
  • ITOS N/A
  • BLDP N/A
  • Revenue
  • ITOS N/A
  • BLDP $72,507,000.00
  • Revenue This Year
  • ITOS N/A
  • BLDP $35.72
  • Revenue Next Year
  • ITOS N/A
  • BLDP $24.94
  • P/E Ratio
  • ITOS N/A
  • BLDP N/A
  • Revenue Growth
  • ITOS 177.89
  • BLDP N/A
  • 52 Week Low
  • ITOS $4.80
  • BLDP $1.00
  • 52 Week High
  • ITOS $18.13
  • BLDP $2.28
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 53.14
  • BLDP 60.04
  • Support Level
  • ITOS $10.08
  • BLDP $1.75
  • Resistance Level
  • ITOS $10.17
  • BLDP $1.87
  • Average True Range (ATR)
  • ITOS 0.04
  • BLDP 0.11
  • MACD
  • ITOS -0.02
  • BLDP -0.01
  • Stochastic Oscillator
  • ITOS 35.29
  • BLDP 85.71

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About BLDP Ballard Power Systems Inc.

Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from Poland followed by United States, United Kingdom, and other countries.

Share on Social Networks: